Home
3rd Saudi MPN Summit on 16 Feb 2012, Jeddah Hilton Hotel, Saudi Arabia...
Research/Open Trials
SSBMT gives high attention to research and researchers. You may want to advertise your trial for recruitment purposes, for instance, or you may have a patient who you think would be a suitable candidate for an ongoing trial. Your cooperation and support would have a great positive impact nationally.
Click on the corresponding title for the details of the following trial…. ...
Some of the information below require journal or site subscription for full access.
SSBMT Newsflash
|
NCCN Tweaks 2011 Multiple Myeloma Guidelines |
|
Antibiotic is potential new leukemia treatment |
|
FDA approved ruxolitinib (Jakafi oral tablets, Incyte Corporation) for the treatment of intermediate and high risk myelofibrosis, including primary myelofibrosis, post-polycythemia vera myelofibrosis and post-essential thrombocythemia myelofibrosis. |
|
FDA granted accelerated approval for the use of eculizumab (Soliris, Alexion, Inc.) for the treatment of pediatric and adult patients with atypical hemolytic uremic syndrome (aHUS). |
News Archives
Click on Play button to watch SSBMT Introductory Video
Follow us on